Clinical Trials List
Protocol NumberMK-0941-017
Not yet recruiting
2009-01-01 - 2010-06-30
Phase II
Terminated3
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- I-TE LEE Division of Endocrinology
- 林耿弘 Division of Endocrinology
- JUN-SING WANG Division of Endocrinology
- 林時逸 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 李弘元 Division of Endocrinology
- 張恬君 Division of Endocrinology
- CHUNG-MAY YANG Division of Endocrinology
- - - Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jin-Shang Wu Division of Family Medicine
- Yi-Ching Yang Division of Family Medicine
- Yi-Sheng Chang Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
0 participants
-
Global
0 participants
